CY1118459T1 - Απο του στοματος φαρμακευτικη συνθεση δεσμοπρεσινης - Google Patents
Απο του στοματος φαρμακευτικη συνθεση δεσμοπρεσινηςInfo
- Publication number
- CY1118459T1 CY1118459T1 CY20171100005T CY171100005T CY1118459T1 CY 1118459 T1 CY1118459 T1 CY 1118459T1 CY 20171100005 T CY20171100005 T CY 20171100005T CY 171100005 T CY171100005 T CY 171100005T CY 1118459 T1 CY1118459 T1 CY 1118459T1
- Authority
- CY
- Cyprus
- Prior art keywords
- pharmaceutical composition
- desmopresin
- oral pharmaceutical
- jürgens
- hemophilia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Obesity (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Η παρούσα εφεύρεση σχετίζεται με μία υγρή από του στόματος φαρμακευτική σύνθεση δεσμοπρεσίνης, και τη χρήση της στη θεραπεία του κεντρικού άποιου διαβήτη, της πρόωρης νυχτερινής ενούρησης, της αιμορραγίας σε ασθενείς με Αιμοφιλία Α, με νόσο von Willebrand - Jürgens και της μετεγχειρητικής αιμορραγίας.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200702215A ES2319054B1 (es) | 2007-08-06 | 2007-08-06 | Composicion farmaceutica oral de desmopresina. |
PCT/ES2008/000539 WO2009027561A2 (es) | 2007-08-06 | 2008-08-01 | Composición farmacéutica oral de desmopresina |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1118459T1 true CY1118459T1 (el) | 2017-07-12 |
Family
ID=40032884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20171100005T CY1118459T1 (el) | 2007-08-06 | 2017-01-03 | Απο του στοματος φαρμακευτικη συνθεση δεσμοπρεσινης |
Country Status (18)
Country | Link |
---|---|
US (1) | US8993521B2 (el) |
EP (1) | EP2174652B1 (el) |
JP (1) | JP5626682B2 (el) |
CN (2) | CN101808621A (el) |
AR (1) | AR068337A1 (el) |
BR (1) | BRPI0814835B8 (el) |
CY (1) | CY1118459T1 (el) |
DK (1) | DK2174652T3 (el) |
ES (2) | ES2319054B1 (el) |
HR (1) | HRP20161676T1 (el) |
HU (1) | HUE032667T2 (el) |
LT (1) | LT2174652T (el) |
MX (1) | MX2010001456A (el) |
PL (1) | PL2174652T3 (el) |
PT (1) | PT2174652T (el) |
RU (1) | RU2474414C2 (el) |
SI (1) | SI2174652T1 (el) |
WO (1) | WO2009027561A2 (el) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO3400B1 (ar) * | 2010-09-30 | 2019-10-20 | Ferring Bv | مركب صيدلاني من كاربيتوسين |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8306367L (sv) | 1983-11-18 | 1985-05-19 | Ferring Ab | Antidiuretiskt verkande farmaceutiskt preparat |
ATE108326T1 (de) | 1989-01-30 | 1994-07-15 | Corint Ltd | Wässerige desmopressin-cmc enthaltende arzneizubereitung. |
JP2653255B2 (ja) * | 1990-02-13 | 1997-09-17 | 武田薬品工業株式会社 | 長期徐放型マイクロカプセル |
CA2070061C (en) | 1991-06-07 | 2004-02-10 | Shigeyuki Takama | Physiologically active polypeptide-containing pharmaceutical composition |
US5298256A (en) | 1992-04-28 | 1994-03-29 | Corint, Ltd. | Desmopressin buccal patch composition |
IT1255460B (it) | 1992-07-28 | 1995-11-02 | Poli Ind Chimica Spa | Composizioni farmaceutiche in forma di microemulsioni o di dispersioni liposomiali bioadesive per la somministrazione transmucosale di sostanze peptidiche e di proteine farmacologicamente attive |
SE9300937L (sv) | 1993-03-19 | 1994-09-20 | Anne Fjellestad Paulsen | Komposition för oral administrering av peptider |
US5482931A (en) * | 1993-06-29 | 1996-01-09 | Ferring Ab | Stabilized pharmaceutical peptide compositions |
SE9400918L (sv) | 1994-03-18 | 1995-09-19 | Anne Fjellstad Paulsen | Stabiliserad komposition för oral administrering av peptider |
US5763398A (en) | 1996-06-20 | 1998-06-09 | Ferring B.V. | Nasal administration of desmopressin |
US20030095926A1 (en) | 1997-10-01 | 2003-05-22 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
RU2232608C2 (ru) * | 1998-11-02 | 2004-07-20 | Элзэ Копэрейшн | Устройство для чрескожной доставки лекарственного средства электропереносом и способ его изготовления, способ чрескожной доставки лекарственного средства пациенту электропереносом |
US6894026B1 (en) | 2000-01-11 | 2005-05-17 | Atossa Healthcare, Inc. | Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders |
EP1121935B1 (en) * | 2000-02-04 | 2008-08-13 | Patents Exploitation Company B.V. | Pharmaceutical composition containing a small or medium size peptide |
AT409081B (de) * | 2000-02-16 | 2002-05-27 | Gebro Pharma Gmbh | Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung |
GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
AU2003269747A1 (en) * | 2002-05-15 | 2003-12-02 | Sun Pharmaceutical Industries Limited | A stable aqueous composition of a peptide |
ITMI20021684A1 (it) | 2002-07-29 | 2004-01-29 | Therapicon Srl | Composizione farmaceutica di peptide nasale |
CA2514325C (en) * | 2003-01-24 | 2013-11-12 | Magle Holding Ab | A composition material for transmucosal delivery |
ATE291419T1 (de) | 2003-04-30 | 2005-04-15 | Ferring Bv | Feste dosierungsform mit desmopressin |
DE60301351T2 (de) | 2003-07-25 | 2006-01-19 | Ferring B.V. | Pharmazeutische Desmopressin-Zubereitung als feste Darreichungsform und Methode zu ihrer Herstellung |
EP2322196A2 (en) | 2003-11-10 | 2011-05-18 | Reprise Biopharmaceutics, LLC | Pharmaceutical compositions including low dosages of desmopressin |
GB0406048D0 (en) | 2004-03-18 | 2004-04-21 | Ardana Bioscience Ltd | Drug formulations |
US20050244502A1 (en) | 2004-04-28 | 2005-11-03 | Mathias Neil R | Composition for enhancing absorption of a drug and method |
-
2007
- 2007-08-06 ES ES200702215A patent/ES2319054B1/es active Active
-
2008
- 2008-08-01 PT PT88053673T patent/PT2174652T/pt unknown
- 2008-08-01 HU HUE08805367A patent/HUE032667T2/en unknown
- 2008-08-01 CN CN200880105631A patent/CN101808621A/zh active Pending
- 2008-08-01 PL PL08805367T patent/PL2174652T3/pl unknown
- 2008-08-01 WO PCT/ES2008/000539 patent/WO2009027561A2/es active Application Filing
- 2008-08-01 CN CN201610700664.8A patent/CN106265494A/zh active Pending
- 2008-08-01 SI SI200831737A patent/SI2174652T1/sl unknown
- 2008-08-01 US US12/672,255 patent/US8993521B2/en active Active
- 2008-08-01 BR BRPI0814835A patent/BRPI0814835B8/pt not_active IP Right Cessation
- 2008-08-01 ES ES08805367.3T patent/ES2608816T3/es active Active
- 2008-08-01 LT LTEP08805367.3T patent/LT2174652T/lt unknown
- 2008-08-01 DK DK08805367.3T patent/DK2174652T3/en active
- 2008-08-01 EP EP08805367.3A patent/EP2174652B1/en active Active
- 2008-08-01 MX MX2010001456A patent/MX2010001456A/es active IP Right Grant
- 2008-08-01 JP JP2010519481A patent/JP5626682B2/ja active Active
- 2008-08-01 RU RU2010105031/15A patent/RU2474414C2/ru active
- 2008-08-06 AR ARP080103430A patent/AR068337A1/es not_active Application Discontinuation
-
2016
- 2016-12-08 HR HRP20161676TT patent/HRP20161676T1/hr unknown
-
2017
- 2017-01-03 CY CY20171100005T patent/CY1118459T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO2009027561A2 (es) | 2009-03-05 |
US8993521B2 (en) | 2015-03-31 |
EP2174652A2 (en) | 2010-04-14 |
WO2009027561A3 (es) | 2009-07-16 |
DK2174652T3 (en) | 2017-01-23 |
CN106265494A (zh) | 2017-01-04 |
JP5626682B2 (ja) | 2014-11-19 |
EP2174652B1 (en) | 2016-10-05 |
HRP20161676T1 (hr) | 2017-02-24 |
RU2474414C2 (ru) | 2013-02-10 |
AR068337A1 (es) | 2009-11-11 |
LT2174652T (lt) | 2017-02-27 |
BRPI0814835B1 (pt) | 2020-10-27 |
RU2010105031A (ru) | 2011-09-20 |
BRPI0814835A2 (pt) | 2015-03-31 |
ES2608816T3 (es) | 2017-04-17 |
ES2319054A1 (es) | 2009-05-01 |
BRPI0814835B8 (pt) | 2021-05-25 |
PT2174652T (pt) | 2016-12-23 |
SI2174652T1 (sl) | 2017-04-26 |
MX2010001456A (es) | 2010-06-02 |
US20110251123A1 (en) | 2011-10-13 |
ES2319054B1 (es) | 2010-02-12 |
PL2174652T3 (pl) | 2017-06-30 |
JP2010535745A (ja) | 2010-11-25 |
HUE032667T2 (en) | 2017-10-30 |
CN101808621A (zh) | 2010-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1122428T1 (el) | Θεραπευτικη αγωγη της παιδιατρικης οξειας λεμφοβλαστικης λευχαιμιας με διειδικα αντισωματα εναντι cd3xcd19 | |
CY1118349T1 (el) | Παραγοντες συνδεσης me cd19 και χρησεις αυτων | |
EA201100958A1 (ru) | Фармацевтическая пероральная дозированная лекарственная форма на основе ингибиторов dpp iv | |
CY1118120T1 (el) | Συνθεσεις βασιζομενες σε πεδιο ινωδονεκτινης τυπου iii, μεθοδοι και χρησεις αυτων | |
CY1115350T1 (el) | Χρησεις αναστολεων της dpp iv | |
CY1114139T1 (el) | Πλακιδιο βουπρενορφινης για τη θεραπεια υποκαταστασης ναρκωτικων | |
UA94734C2 (ru) | ТЕРАПЕВТИЧЕСКОЕ АНТИТЕЛО, КОТОРОЕ СВЯЗЫВАЕТСЯ С b-АМИЛОИДНЫМ ПЕПТИДОМ | |
CY1115254T1 (el) | Φαρμακευτικα διαλυματα, διαδικασιες για την παρασκευη τους και θεραπευτικες χρησεις | |
CY1112813T1 (el) | 4-(4-κυανο-2-θειοαρυλ)διϋδροπυριμιδινονες και η χρηση αυτων | |
CY1114272T1 (el) | Υποκατεστημενες διυδροπυραζολονες για την θεραπευτικη αντιμετωπιση των καρδιαγγειακων και αιματολογικων παθησεων | |
CY1111713T1 (el) | Συνθεση δισκιου εκτεταμενης απελευθερωσεως περιεχουσα πραμιπεξολη ή ενα φαρμακευτικα αποδεκτο αλας της, μεθοδος παραγωγης της και χρηση τους | |
CY1111613T1 (el) | Μεθοδοι για την αντιμετωπιση της μολυνσης απο hiv | |
CY1113136T1 (el) | Αντιμετωπιση των διαταραχων των χονδρων με ton fgf-18 | |
CY1115381T1 (el) | Διενυδρη υδροχλωρικη ναλμεφαινη | |
CY1112738T1 (el) | Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη | |
CY1119850T1 (el) | Χρηση της μετφορμινης σε συνδυασμο με ενεργοποιητη γλυκοκινασης και συνθεσεων που περιλαμβανουν μετφορμινη και ενεργοποιητη γλυκοκινασης | |
CY1113178T1 (el) | Σταθεροποιημενες αμορφες μορφες της μεσυλικης ιματινιβης | |
CY1122492T1 (el) | Φορεας για χορηγηση στον στοματικο βλεννογονο, ειδικα για υπογλωσσια χορηγηση, δραστικων φυσιολογικα ουσιων | |
CY1115384T1 (el) | Αντι-φλεγμονωδης συνθεση | |
CY1114045T1 (el) | Φαρμακευτικη συνθεση με παρατεταμενη απελευθερωση οξικης οκτρεοτιδης | |
CY1116840T1 (el) | Χρηση 24-norudca | |
CY1115194T1 (el) | Χρηση της μακρας πεντραξινης ptx3 για την προληψη ή θεραπεια ιικων ασθενειων | |
CY1113551T1 (el) | Υποκατεστημενες ενωσεις νικοτιναμιδιου και η χρησιμοποιηση τους σε φαρμακα | |
CY1120368T1 (el) | Αλληλουχια ειδικης διασπασης μμρ-14 | |
CY1118459T1 (el) | Απο του στοματος φαρμακευτικη συνθεση δεσμοπρεσινης |